Morning Briefing
Summaries of health policy coverage from major news organizations
Botox Maker Agrees To Pay $600 Million For Misbranding
Allergan Inc., the maker of Botox, agrees to pay $600 million to settle a long federal investigation into its marketing of the drug.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
